This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kum, W W Articles by Chow, A W Search for Related Content PubMed PubMed Citation Articles by Kum, W W Articles by Chow, A W

Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1.

Department of Medicine, University of British Columbia, Vancouver General Hospital, Canada.

ABSTRACT

An improved method for producing highly purified toxic shock syndrome toxin 1 (TSST-1) by preparative isoelectric focusing in a Bio-Rad Rotofor cell and then chromatofocusing is described. Purification to homogeneity was confirmed by silver staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE; 50 micrograms of protein was loaded), by immunoblotting with polyclonal rabbit antiserum raised against the crude culture supernatant used for purification, and by autoradiography after iodination and SDS-PAGE. Biologic activity was demonstrated by mitogenicity and cytokine induction (tumor necrosis factor alpha [TNF-alpha], interleukin 1-beta [IL-1 beta], and IL-6) of human peripheral blood mononuclear cells (PBMCs) and by lethality in New Zealand White rabbits following subcutaneous infusion. In contrast to commercial TSST-1 preparations, our TSST-1 preparation required the presence of both monocytes and T cells for the induction of TNF-alpha and IL-1 beta from human PBMCs. A 46-kDa contaminating protein in the commercial TSST-1 preparation, identified as staphylococcal lipase, was likely responsible for the induction of TNF-alpha and IL-1 beta from human monocytes in the absence of T cells, a biologic activity falsely attributed to purified TSST-1. Our improved purification procedure for TSST-1 provides a high yield and is both more rapid and less labor intensive than previously reported methods. Furthermore, our studies clearly demonstrate the need for stringent methods of purity assessment of TSST-1 preparations before ascribing to them their potent biologic activities.

This article has been cited by other articles:

• Kum, W. W. S., Cameron, S. B., Hung, R. W. Y., Kalyan, S., Chow, A. W. (2001). Temporal Sequence and Kinetics of Proinflammatory and Anti-Inflammatory Cytokine Secretion Induced by Toxic Shock Syndrome Toxin 1 in Human Peripheral Blood Mononuclear Cells. Infect. Immun. 69: 7544-7549 [Abstract] [Full Text]  
• Lei, L., Altstaedt, J., von der Ohe, M., Proft, T., Gross, U., Rink, L. (2001). Induction of interleukin-8 in human neutrophils after MHC class II cross-linking with superantigens. J. Leukoc. Biol. 70: 80-86 [Abstract] [Full Text]  
• Lennon, G. P., Sillibourne, J. E., Furrie, E., Doherty, M. J., Kay, R. A. (2000). Antigen Triggering Selectively Increases TCRBV Gene Transcription. J. Immunol. 165: 2020-2027 [Abstract] [Full Text]  
• Pang, L. T. Y., Kum, W. W. S., Chow, A. W. (2000). Inhibition of Staphylococcal Enterotoxin B-Induced Lymphocyte Proliferation and Tumor Necrosis Factor Alpha Secretion by MAb5, an Anti-Toxic Shock Syndrome Toxin 1 Monoclonal Antibody. Infect. Immun. 68: 3261-3268 [Abstract] [Full Text]